ALGN
Price
$133.04
Change
+$1.98 (+1.51%)
Updated
Sep 16, 12:10 PM (EDT)
Capitalization
9.5B
43 days until earnings call
BLFS
Price
$25.91
Change
+$0.11 (+0.43%)
Updated
Sep 16, 12:13 PM (EDT)
Capitalization
1.24B
51 days until earnings call
Interact to see
Advertisement

ALGN vs BLFS

Header iconALGN vs BLFS Comparison
Open Charts ALGN vs BLFSBanner chart's image
Align Technology
Price$133.04
Change+$1.98 (+1.51%)
Volume$200
Capitalization9.5B
BioLife Solutions
Price$25.91
Change+$0.11 (+0.43%)
Volume$300
Capitalization1.24B
ALGN vs BLFS Comparison Chart in %
Loading...
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALGN vs. BLFS commentary
Sep 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and BLFS is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 16, 2025
Stock price -- (ALGN: $131.06 vs. BLFS: $25.80)
Brand notoriety: ALGN: Notable vs. BLFS: Not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ALGN: 61% vs. BLFS: 86%
Market capitalization -- ALGN: $9.5B vs. BLFS: $1.24B
ALGN [@Pharmaceuticals: Other] is valued at $9.5B. BLFS’s [@Pharmaceuticals: Other] market capitalization is $1.24B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $155.58B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALGN’s FA Score shows that 0 FA rating(s) are green whileBLFS’s FA Score has 1 green FA rating(s).

  • ALGN’s FA Score: 0 green, 5 red.
  • BLFS’s FA Score: 1 green, 4 red.
According to our system of comparison, BLFS is a better buy in the long-term than ALGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALGN’s TA Score shows that 5 TA indicator(s) are bullish while BLFS’s TA Score has 5 bullish TA indicator(s).

  • ALGN’s TA Score: 5 bullish, 2 bearish.
  • BLFS’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ALGN is a better buy in the short-term than BLFS.

Price Growth

ALGN (@Pharmaceuticals: Other) experienced а -4.24% price change this week, while BLFS (@Pharmaceuticals: Other) price change was -1.60% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.92%. For the same industry, the average monthly price growth was +3.56%, and the average quarterly price growth was +5.94%.

Reported Earning Dates

ALGN is expected to report earnings on Oct 29, 2025.

BLFS is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+0.92% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALGN($9.5B) has a higher market cap than BLFS($1.24B). BLFS YTD gains are higher at: -0.616 vs. ALGN (-37.145). ALGN has higher annual earnings (EBITDA): 793M vs. BLFS (17.4M). ALGN has more cash in the bank: 901M vs. BLFS (81.8M). BLFS has less debt than ALGN: BLFS (23.8M) vs ALGN (123M). ALGN has higher revenues than BLFS: ALGN (3.97B) vs BLFS (93.5M).
ALGNBLFSALGN / BLFS
Capitalization9.5B1.24B769%
EBITDA793M17.4M4,557%
Gain YTD-37.145-0.6166,027%
P/E Ratio22.14N/A-
Revenue3.97B93.5M4,241%
Total Cash901M81.8M1,101%
Total Debt123M23.8M517%
FUNDAMENTALS RATINGS
ALGN vs BLFS: Fundamental Ratings
ALGN
BLFS
OUTLOOK RATING
1..100
5211
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
99
Overvalued
PROFIT vs RISK RATING
1..100
10088
SMR RATING
1..100
6692
PRICE GROWTH RATING
1..100
6553
P/E GROWTH RATING
1..100
9414
SEASONALITY SCORE
1..100
2585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALGN's Valuation (74) in the Medical Specialties industry is in the same range as BLFS (99). This means that ALGN’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Profit vs Risk Rating (88) in the Medical Specialties industry is in the same range as ALGN (100). This means that BLFS’s stock grew similarly to ALGN’s over the last 12 months.

ALGN's SMR Rating (66) in the Medical Specialties industry is in the same range as BLFS (92). This means that ALGN’s stock grew similarly to BLFS’s over the last 12 months.

BLFS's Price Growth Rating (53) in the Medical Specialties industry is in the same range as ALGN (65). This means that BLFS’s stock grew similarly to ALGN’s over the last 12 months.

BLFS's P/E Growth Rating (14) in the Medical Specialties industry is significantly better than the same rating for ALGN (94). This means that BLFS’s stock grew significantly faster than ALGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALGNBLFS
RSI
ODDS (%)
Bullish Trend 5 days ago
68%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 12 days ago
73%
Bullish Trend 6 days ago
76%
Declines
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 20 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
ALGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTRX35.270.16
+0.46%
Artisan Global Opportunities Inv
WBBIX10.60N/A
N/A
TETON Westwood Balanced I
SILVX18.38N/A
N/A
SGI US Large Cap Equity I
AMTZX10.17N/A
N/A
AB All Market Real Return Z
BBVSX15.38-0.04
-0.26%
Bridge Builder Small/Mid Cap Value

ALGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALGN has been closely correlated with BAX. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if ALGN jumps, then BAX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALGN
1D Price
Change %
ALGN100%
-0.38%
BAX - ALGN
71%
Closely correlated
-0.79%
NVST - ALGN
54%
Loosely correlated
+0.57%
LUNG - ALGN
52%
Loosely correlated
-6.47%
SAUHY - ALGN
49%
Loosely correlated
-0.87%
ILMN - ALGN
48%
Loosely correlated
+6.10%
More

BLFS and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with RGEN. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then RGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+1.14%
RGEN - BLFS
58%
Loosely correlated
+0.18%
RVTY - BLFS
51%
Loosely correlated
+1.36%
A - BLFS
50%
Loosely correlated
+1.94%
DHR - BLFS
47%
Loosely correlated
-0.79%
ITGR - BLFS
46%
Loosely correlated
-1.13%
More